US Merger & Acquisition SEC Filings — April 03, 2026

03-04-2026

On April 1, 2026, Jena Acquisition Corporation II, a blank check SPAC, received a notice from NYSE Regulation for non-compliance with Section 802.01A of the NYSE Listed Company Manual, failing to maintain a minimum of 300 public shareholders. The company plans to submit a business plan within 45 days outlining regaining compliance within 18 months through a de-SPAC transaction, with no immediate impact on the listing or trading of its securities (JENA.U, JENA, JENA.R). This deficiency highlights ongoing challenges in attracting sufficient public shareholders, posing delisting risks if unresolved.

• ·Company intends to focus on targets benefiting from management expertise in real estate & construction.
• ·Press release issued April 3, 2026, references slightly different rule (Section 802.01B).
• ·NYSE has 45 days to review the submitted business plan.

03-04-2026

Drugs Made in America Acquisition Corp II (DMIIU) entered into a Definitive Investment and Sponsor Transition Agreement on March 23, 2026, with Tal Alpha Yezum Vekidum Asakim (2003) LTD for a total financing commitment of $1,400,000 to fund audit, SEC filings, Nasdaq fees, legal costs, and de-SPAC transaction preparation. Of this, $150,000 has been received, $300,000 is due by March 30, 2026, and $950,000 is reserved in escrow; however, the existing sponsor is described as non-performing and subject to legal constraints, necessitating a transition facilitated by the Company. The agreement includes a 4-month timeline to execute an investor-introduced transaction agreement in principle and 6-month exclusivity, with convertible notes at a 35% discount to post-merger market value.

• ·Exclusivity period: 6 months
• ·Timeline: Execute agreement in principle within 4 months
• ·Investor right of first refusal on additional capital beyond $1.4M
• ·No claim on trust account for convertible notes
• ·Maturity of Interim Convertible Note: 9 months from issuance
• ·Governing law: Cayman Islands
• ·Prior agreements superseded: LOI dated March 5, 2026; Addendum No. 1 dated March 9, 2026; Interim Convertible Note dated March 9, 2026; Sponsor Standstill Agreement dated March 18, 2026

03-04-2026

Inflection Point Acquisition Corp. V entered into Amendment No. 2 to its Promissory Note with Inflection Point Fund I LP on April 2, 2026, increasing the principal amount from $700,000 to $800,000 to provide additional working capital. This follows an original note dated February 12, 2025, for up to $500,000 (fully advanced) originally from Maywood Sponsor, LLC and assigned to the Payee on September 9, 2025, with a first amendment on January 7, 2026, raising it to $700,000. No other changes to the note terms were made.

• ·Promissory Note originally executed by Maywood Acquisition Corp. (former name of Inflection Point Acquisition Corp. V)
• ·Governed by the laws of the State of New York
• ·SEC 8-K filed on April 03, 2026, covering Items 1.01, 2.03, and 9.01

03-04-2026

Crown Reserve Acquisition Corp. I (SPAC), a Cayman Islands exempted company, entered into a Business Combination Agreement dated March 30, 2026, with CRAC Merger Sub Inc. and Carvix, Inc., providing for SPAC's domestication to Delaware followed by a merger where Merger Sub merges with Carvix, with Carvix surviving as SPAC's wholly-owned subsidiary. The transaction includes stockholder support agreements from key Carvix stockholders, plans for PIPE financing meeting a minimum investment amount and a committed ELOC, an Investor Rights Agreement, and earnout shares for eligible Carvix equityholders based on post-merger EBITDA and revenue performance over three years. All relevant boards have unanimously approved the agreement and recommended it to shareholders.

03-04-2026

Future Money Acquisition Corporation consummated its initial public offering (IPO) on March 30, 2026, selling 11,200,000 units at $10.00 per unit, generating gross proceeds of $112,000,000. Simultaneously, the company completed a private placement of 304,000 units to sponsor Future Wealth Capital Corp. at $10.00 per unit for $3,040,000 in gross proceeds. A total of $112,560,000 from both was placed in a trust account, after offsetting a $290,855 sponsor loan, with an audited balance sheet issued as Exhibit 99.1.

• ·Units consist of one ordinary share (par value $0.0001) and one right entitling holder to one-fifth of one ordinary share upon initial business combination.
• ·Trading symbols: FMACU (Units), FMAC (Ordinary Shares), FMACR (Rights) on Nasdaq.
• ·Audited balance sheet as of March 30, 2026, included as Exhibit 99.1.

03-04-2026

NMP Acquisition Corp., a Cayman Islands-incorporated blank check company, filed an 8-K on April 3, 2026, to make available its PFIC Annual Statement for fiscal year 2025 (January 1 to December 31, 2025) to Class A ordinary shareholders, enabling optional QEF Elections under IRC Section 1295. The statement discloses minimal ordinary earnings of $0.0006411382 per unit per day, zero net capital gains, and no cash or property distributions. No operational or financial performance metrics or period-over-period changes are reported.

• ·PFIC tax period: January 1, 2025 to December 31, 2025
• ·Net Capital Gains: $0
• ·Distributions: Cash NONE; Fair Market Value of property: NONE
• ·Date of Incorporation: December 18, 2024
• ·Principal executive offices: 555 Bryant Street, No. 590, Palo Alto, CA 94301
• ·Trading on Nasdaq Stock Market LLC
• ·Emerging growth company: Yes